Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 3
2008 2
2011 1
2012 1
2013 2
2014 1
2015 2
2016 2
2017 3
2018 4
2019 2
2020 3
2021 5
2022 9
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Ending Malaria: Where Are We?
Tavares J, Cordeiro-da-Silva A, Calderón F. Tavares J, et al. Among authors: calderon f. ACS Infect Dis. 2024 Apr 24. doi: 10.1021/acsinfecdis.4c00248. Online ahead of print. ACS Infect Dis. 2024. PMID: 38656180 No abstract available.
Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery.
Russell CN, Carter JL, Borgia JM, Bush J, Calderón F, Gabarró R, Conway SJ, Mottram JC, Wilkinson AJ, Jones NG. Russell CN, et al. Among authors: calderon f. ACS Infect Dis. 2023 Nov 10;9(11):2340-2357. doi: 10.1021/acsinfecdis.3c00431. Epub 2023 Oct 31. ACS Infect Dis. 2023. PMID: 37906637 Free PMC article.
Virtual Special Issue: Epigenetics 2022.
Aldrich CC, Calderón F, Conway SJ, He C, Hooker JM, Huryn DM, Lindsley CW, Liotta DC, Müller CE. Aldrich CC, et al. Among authors: calderon f. ACS Chem Biol. 2022 Oct 21;17(10):2673-2678. doi: 10.1021/acschembio.2c00661. ACS Chem Biol. 2022. PMID: 36268572 No abstract available.
Virtual Special Issue: Epigenetics 2022.
Aldrich CC, Calderón F, Conway SJ, He C, Hooker JM, Huryn DM, Lindsley CW, Liotta DC, Müller CE. Aldrich CC, et al. Among authors: calderon f. ACS Pharmacol Transl Sci. 2022 Sep 9;5(10):829-834. doi: 10.1021/acsptsci.2c00169. eCollection 2022 Oct 14. ACS Pharmacol Transl Sci. 2022. PMID: 36268124 Free PMC article. No abstract available.
Virtual Special Issue: Epigenetics 2022.
Aldrich CC, Calderón F, Conway SJ, He C, Hooker JM, Huryn DM, Lindsley CW, Liotta DC, Müller CE. Aldrich CC, et al. Among authors: calderon f. ACS Med Chem Lett. 2022 Oct 13;13(10):1524-1529. doi: 10.1021/acsmedchemlett.2c00393. eCollection 2022 Oct 13. ACS Med Chem Lett. 2022. PMID: 36262399 Free PMC article. No abstract available.
Virtual Special Issue: Epigenetics 2022.
Aldrich CC, Calderón F, Conway SJ, He C, Hooker JM, Huryn DM, Lindsley CW, Liotta DC, Müller CE. Aldrich CC, et al. Among authors: calderon f. J Med Chem. 2022 Sep 22;65(18):11894-11899. doi: 10.1021/acs.jmedchem.2c01386. Epub 2022 Sep 8. J Med Chem. 2022. PMID: 36073827 No abstract available.
Virtual Special Issue: Epigenetics 2022.
Aldrich CC, Calderón F, Conway SJ, He C, Hooker JM, Huryn DM, Lindsley CW, Liotta DC, Müller CE. Aldrich CC, et al. Among authors: calderon f. ACS Infect Dis. 2022 Oct 14;8(10):1975-1980. doi: 10.1021/acsinfecdis.2c00434. Epub 2022 Sep 8. ACS Infect Dis. 2022. PMID: 36073808 No abstract available.
Bromodomain factor 5 is an essential regulator of transcription in Leishmania.
Jones NG, Geoghegan V, Moore G, Carnielli JBT, Newling K, Calderón F, Gabarró R, Martín J, Prinjha RK, Rioja I, Wilkinson AJ, Mottram JC. Jones NG, et al. Among authors: calderon f. Nat Commun. 2022 Jul 13;13(1):4071. doi: 10.1038/s41467-022-31742-1. Nat Commun. 2022. PMID: 35831302 Free PMC article.
Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin.
Johnson RC, Sáez-López E, Anagonou ES, Kpoton GG, Ayelo AG, Gnimavo RS, Mignanwande FZ, Houezo JG, Sopoh GE, Addo J, Orford L, Vlasakakis G, Biswas N, Calderon F, Della Pasqua O, Gine-March A, Herrador Z, Mendoza-Losana A, Díez G, Cruz I, Ramón-García S. Johnson RC, et al. Among authors: calderon f. Trials. 2022 Jul 8;23(1):559. doi: 10.1186/s13063-022-06473-9. Trials. 2022. PMID: 35804454 Free PMC article.
42 results